Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa In The News.
Press releases published on September 23, 2025
Evfarmer Announces $40 Million Investment in Sierra Leone to Advance Local Agriculture
Evfarmer announces a $40M investment in Sierra Leone to enhance agriculture, create jobs, and expand global market access for local farmers. FREETOWN, SIERRA LEONE, September 23, 2025 /EINPresswire.com/ -- Evfarmer, a globally recognized agricultural …
EDUCATION ABOVE ALL FOUNDATION BREAKS BARRIERS TO EDUCATION FOR CHILDREN AND YOUTH IN ZAMBIA
DOHA, QATAR, September 23, 2025 /EINPresswire.com/ -- As the United Nations General Assembly convenes under the theme “Better together: 80 years and more for peace, development and human rights,” the Education Above All (EAA) Foundation is reaffirming …
The largest eVTOL Expo in China was held Sep. 23-25 in Shenzhen
SHENZHEN, CHINA, September 23, 2025 /EINPresswire.com/ -- The 2025 Shenzhen eVTOL Expo held in Shenzhen from September 23 to 25. With the theme of "low-altitude economy, eVTOL, aviation emergency rescue, and large-scale commercial cargo drones", creating …
Baltimore Hustle Premieres at the 20th Annual PVIFF with Simultaneous Streaming Release on JaroGO
ATLANTA, GA, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- The 20th Annual Peachtree Village International Film Festival (PVIFF) is proud to announce the highly anticipated premiere of the feature film Baltimore Hustle on Friday, October 17, …
Wearable Electronics Market to Reach USD 704.1 Billion by 2033 | CAGR 16.59%
The global wearable electronics market is projected to grow from USD 165.4 billion in 2024 to USD 704.1 billion by 2033. INDORE, INDIA, September 23, 2025 /EINPresswire.com/ -- The global Wearable Electronics Market is projected to grow from USD 165.4 …
Next Generation Cancer Diagnostics Market to Reach USD 41.44 Billion by 2033 | CAGR 11.15%
The global Next Generation Cancer Diagnostics Market is projected to grow from USD 16.61 billion in 2024 to USD 41.44 billion by 2033. INDORE, INDIA, September 23, 2025 /EINPresswire.com/ -- The global Next Generation Cancer Diagnostics Market is …
International Solar Alliance and African Leaders Unite in Accra to Chart Pathways for Africa's Solar Future
ACCRA, GHANA, September 23, 2025 /EINPresswire.com/ -- International Solar Alliance and African Leaders Unite in Accra to Chart Pathways for Africa's Solar Future The Seventh Meeting of the International Solar Alliance (ISA) Regional Committee for …
Insulated Packaging Market Size to Reach USD 37.8 Billion by 2035 | Growth at 7.0% CAGR
The global insulated packaging market will grow from USD 19.2 billion in 2025 to USD 37.8 billion by 2035 at a CAGR of 7.0%. INDORE, INDIA, September 23, 2025 /EINPresswire.com/ -- The Global Insulated Packaging Market is projected to grow from USD 19.2 …
Global Next Generation Sequencing (NGS) Market Size to Reach USD 58.9 Billion by 2035 at 15% CAGR
The Global Next Generation Sequencing (NGS) Market will grow from USD 12.65 billion in 2024 to USD 58.9 billion by 2035 INDORE, INDIA, September 23, 2025 /EINPresswire.com/ -- The Global Next Generation Sequencing (NGS) Market is projected to grow from …
Avidian Gold Corp. Files Early Warning Report in Respect of High Tide Resources Corp.
TORONTO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Avidian Gold Corp. (“Avidian” or the “Corporation”) (TSX-V: AVG) today announces that it has closed the first tranche of a share purchase agreement dated September 16, 2025 (the “Agreement”) with an arm’s length …
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CHASKA, Minn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on September 22, 2025, the Lifecore compensation …
Aardvark Therapeutics to Present at the Stifel 2025 Virtual Cardiometabolic Forum
SAN DIEGO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the …
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”) Announces Signing of a Securities Purchase Agreement with an Institutional Investor for the Purchase of $100 Million of shares of Se…
PALO ALTO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR, SMNRW) , a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid …
Highlander Silver Announces Upsizing of Previously Announced Bought Deal Public Offering of Common Shares
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES THE SHELF PROSPECTUS SUPPLEMENT, THE CORRESPONDING BASE SHELF PROSPECTUS AND ANY AMENDMENT TO THE DOCUMENTS ARE ACCESSIBLE THROUGH SEDAR+ OR WILL BE ACCESSIBLE …
Biofrontera Inc. Engages Lytham Partners to Lead Strategic Investor Relations and Shareholder Communication Program
WOBURN, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), has engaged Lytham Partners …
Silo Pharma Signs Strategic Agreement with Fireblocks to Advance Crypto Treasury Strategy Acquisition and Security
SARASOTA, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that it has engaged Fireblocks, an …
Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity
MIAMI, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced a successful …